ALDOB
EmergingALDOB deficiency causes hereditary fructose intolerance, now diagnosed via genetic testing rather than a provocative fructose challenge.
This enzyme is needed to process fructose (fruit sugar). Without it, eating fructose or table sugar causes serious symptoms. Modern genetic testing has replaced an older, riskier test that involved giving fructose directly to see what happened, and treatment is simply avoiding these sugars for life.
ALDOB encodes aldolase B, a liver enzyme involved in fructose metabolism; its deficiency causes hereditary fructose intolerance (HFI), a genetic condition with potentially severe consequences from fructose/sucrose ingestion.
Deficient aldolase B activity causes accumulation of toxic fructose-1-phosphate after fructose consumption, leading to vomiting, hypoglycemia, and progressive liver damage if the condition goes unrecognized and dietary fructose isn't avoided.
Diagnosis increasingly relies on ALDOB gene sequencing rather than the older, riskier IV fructose tolerance test (which can itself trigger a dangerous reaction), reflecting a broader trend toward genetic confirmation over provocative testing across many metabolic disorders discussed in this biomarker set.
Management is simply lifelong dietary fructose, sucrose, and sorbitol avoidance; there is no enzyme replacement or other pharmacologic therapy, making early diagnosis and dietary counseling the primary intervention.
Represents a broader trend across metabolic disorders toward genetic confirmation over risky provocative testing.
- General metabolic genetics reference literature on hereditary fructose intolerance diagnosis and management.